Articles

I promised an update on the Metformin recall. The FDA has been in contact with five companies to recommend that they voluntarily recall Extended Release metformin due to unacceptable levels of a possible carcinogen called NDMA.

The companies are Apotex, Amneal, Marksans, Lupin, Teva/Actavis.

Symptoms are signs. Do you pay attention or ignore them?

Symptom, a physical or mental feature which is regarded as indicating a condition of disease, particularly such a feature that is apparent to the patient. Have you noticed any of the following symptoms?

• Fatigue, frequently tired or have that foggy feeling
• Difficulty maintaining a healthy weight
• Broken sleep having to urinate too often
• Vision changes such as floaters, blurred vision, dark or empty spots

On May 28, 2020, the FDA announced a recall on Metformin and earlier on some ranitidine medicines, better known as Zantac to contain a nitrosamine impurity called NDMA, which is classified as a probable human carcinogen.

As a country, we have been on an emotional roller coaster ride waiting for the next horrible announcement regarding the coronavirus. Rightly being concerned having an underlying condition has greatly added to our fears.

People with diabetes are 2 to 3 times more likely to have depression than people without diabetes. Unfortunately, only 25% to 50% of diabetes patients who have depression get diagnosed and treated.[1]

Getting a diabetes diagnosis can be like a roller coaster ride. Consistent glucose levels can be difficult to achieve especially when prescribed insulin. Depression and anxiety may be likely.